Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Difficult asthma: assessment and management, Part 2.

Fanta CH, Long AA.

Allergy Asthma Proc. 2012 Jul-Aug;33(4):313-23. doi: 10.2500/aap.2012.33.3577.

PMID:
22856632
2.

Omalizumab for asthma in adults and children.

Normansell R, Walker S, Milan SJ, Walters EH, Nair P.

Cochrane Database Syst Rev. 2014 Jan 13;(1):CD003559. doi: 10.1002/14651858.CD003559.pub4. Review.

PMID:
24414989
3.

[Latin-American Consensus on Difficult-to-Control Asthma. 2008 Update].

[No authors listed]

Drugs Today (Barc). 2008 Jun;44 Suppl 3:1-43. Review. Spanish.

PMID:
19093041
4.

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.

Pediatrics. 2001 Aug;108(2):E36.

PMID:
11483846
5.

Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.

Chipps BE, Figliomeni M, Spector S.

Allergy Asthma Proc. 2012 Sep-Oct;33(5):377-85. doi: 10.2500/aap.2012.33.3599.

PMID:
23026179
6.

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.

Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N.

Pharmacoeconomics. 2012 Nov 1;30(11):991-1004. doi: 10.2165/11597160-000000000-00000. Review.

PMID:
22950547
7.

The impact of asthma exacerbations and preventive strategies.

Graham LM, Eid N.

Curr Med Res Opin. 2015 Apr;31(4):825-35. doi: 10.1185/03007995.2014.1001062. Epub 2015 Feb 9. Review.

PMID:
25530129
8.

Refractory asthma - beyond step 5, the role of new and emerging adjuvant therapies.

Kane B, Fowler SJ, Niven R.

Chron Respir Dis. 2015 Feb;12(1):69-77. doi: 10.1177/1479972314562210. Epub 2014 Dec 9. Review.

PMID:
25492977
9.

Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).

Rubin AS, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM; QUALITX Study Investigators.

J Asthma. 2012 Apr;49(3):288-93. doi: 10.3109/02770903.2012.660297. Epub 2012 Feb 23.

PMID:
22356355
10.

Anti-IgE for chronic asthma in adults and children.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003559. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003559.

PMID:
16625585
11.

Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience.

Tzortzaki EG, Georgiou A, Kampas D, Lemessios M, Markatos M, Adamidi T, Samara K, Skoula G, Damianaki A, Schiza S, Tzanakis N, Siafakas NM.

Pulm Pharmacol Ther. 2012 Feb;25(1):77-82. doi: 10.1016/j.pupt.2011.11.004. Epub 2011 Dec 3.

PMID:
22155001
12.

Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments.

Pelaia G, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Maselli R.

Curr Drug Targets. 2015;16(2):171-8. Review.

PMID:
25523898
13.

Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.

Hanania NA, Alpan O, Hamilos DL, Condemi JJ, Reyes-Rivera I, Zhu J, Rosen KE, Eisner MD, Wong DA, Busse W.

Ann Intern Med. 2011 May 3;154(9):573-82. doi: 10.7326/0003-4819-154-9-201105030-00002.

14.

Omalizumab in the treatment of asthma.

Tan R, Corren J.

Expert Rev Respir Med. 2011 Dec;5(6):747-56. doi: 10.1586/ers.11.73. Review.

PMID:
22082161
15.

Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma.

Pelaia G, Gallelli L, Romeo P, Renda T, Busceti MT, Proietto A, Grembiale RD, Marsico SA, Maselli R, Vatrella A.

Int J Clin Pharmacol Ther. 2011 Dec;49(12):713-21.

PMID:
22122813
16.

Omalizumab: a review of its use in patients with severe persistent allergic asthma.

McKeage K.

Drugs. 2013 Jul;73(11):1197-212. doi: 10.1007/s40265-013-0085-4. Review.

PMID:
23812924
17.

The role of omalizumab in the treatment of severe allergic asthma.

Chapman KR, Cartier A, H├ębert J, McIvor RA, Schellenberg RR.

Can Respir J. 2006 Jul-Aug;13 Suppl B:1B-9B. Review.

18.

Anti-IgE for chronic asthma in adults and children.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2004;(3):CD003559. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003559.

PMID:
15266491
19.

Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: a 6-year pragmatic data review.

Storms W, Bowdish MS, Farrar JR.

Allergy Asthma Proc. 2012 Mar-Apr;33(2):172-7. doi: 10.2500/aap.2012.33.3527.

PMID:
22525394
20.

Asthma: pathogenesis and novel drugs for treatment.

Olin JT, Wechsler ME.

BMJ. 2014 Nov 24;349:g5517. doi: 10.1136/bmj.g5517. Review.

Supplemental Content

Support Center